跳至主要内容
临床试验/NCT02714829
NCT02714829已完成不适用

Clinical Study to Evaluate Efficacy and Safety of "Inject BMP(Beta-TCP Containing rhBMP-2)" for Socket Preservation After Extraction of a Single-rooted Tooth: A Randomized, Outcomes Assessor-Blinded, Multi-center, Prospective Trial.

BioAlpha Inc.0 个研究点目标入组 88 人开始时间: 2016年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
88
主要终点
compared the changed height and standard height by computed tomography.

研究概览

简要总结

This is a prospective, outcomes assessor-blinded, randomized study to evaluate the efficacy and safety of "Inject BMP(Injectable Ceramics Bone Graft Substitute Containing rhBMP-2)" for socket preservation after extraction of a single-rooted tooth, compared to ExcelOS-inject(Injectable Ceramics Bone Graft Substitute).

详细描述

Inject BMP is Injectable Ceramics Bone Graft Substitute(ExcelOS-inject) containing rhBMP-2. Recombinant human Bone morphogenetic protein 2 (rhBMP-2) stimulates the production of bone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
19 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Persons without periodontal disease

排除标准

  • •Women who are pregnant or plan to be pregnant within study period

研究组 & 干预措施

Inject BMP

Experimental

ExcelOS-inject containing rhBMP-2

干预措施: Inject BMP (Device)

ExcelOS-inject

Active Comparator

ExcelOS-inject without rhBMP-2

干预措施: ExcelOS-inject (Device)

结局指标

主要结局

compared the changed height and standard height by computed tomography.

时间窗: at 12 weeks after surgery

次要结局

未报告次要终点

研究者

发起方
BioAlpha Inc.
申办方类型
Industry
责任方
Sponsor

相似试验